Page last updated: 2024-09-04

beta-lactams and Lymphoma, Non-Hodgkin

beta-lactams has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burke, TR; Goydel, RS; Hymel, D; Li, X; Nanna, AR; Pedzisa, L; Rader, C; Roush, WR; Walseng, E	1

Other Studies

1 other study(ies) available for beta-lactams and Lymphoma, Non-Hodgkin

Article	Year
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates. Nature communications, 2017, 10-24, Volume: 8, Issue:1 Topics: Animals; Antineoplastic Agents; beta-Lactams; Catalysis; Cell Line, Tumor; Chemistry, Pharmaceutical; Epitopes, T-Lymphocyte; Female; Humans; Hydrogen-Ion Concentration; Immunoconjugates; K562 Cells; Lymphoma, Non-Hodgkin; Lysine; Mice; Multiple Myeloma; Mutation; Neoplasm Transplantation; Pharmaceutical Preparations; Syndecan-1; Trastuzumab; Xenograft Model Antitumor Assays	2017

Article

Year

Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.

Nature communications, 2017, 10-24, Volume: 8, Issue:1

Topics: Animals; Antineoplastic Agents; beta-Lactams; Catalysis; Cell Line, Tumor; Chemistry, Pharmaceutical; Epitopes, T-Lymphocyte; Female; Humans; Hydrogen-Ion Concentration; Immunoconjugates; K562 Cells; Lymphoma, Non-Hodgkin; Lysine; Mice; Multiple Myeloma; Mutation; Neoplasm Transplantation; Pharmaceutical Preparations; Syndecan-1; Trastuzumab; Xenograft Model Antitumor Assays

2017